{"id":780122,"date":"2022-04-20T08:00:22","date_gmt":"2022-04-20T06:00:22","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/"},"modified":"2023-07-11T14:18:27","modified_gmt":"2023-07-11T12:18:27","slug":"unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/","title":{"rendered":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials"},"content":{"rendered":"Led by Insight Partners, financing builds on the company\u2019s momentum in working with leading biopharmaceutical companies to improve clinical trial efficiency and increase confidence in results\n\n\nSAN FRANCISCO--(BUSINESS WIRE)--#AI--Unlearn\u00ae, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today announced that it has closed a $50 million Series B funding round. The financing was led by New York-based global venture capital and private equity firm Insight Partners with participation from new investor Radical Ventures, as well as all of the company\u2019s existing investors including 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures. Through its inve
Abbonati<\/a> o Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"

Led by Insight Partners, financing builds on the company\u2019s momentum in working with leading biopharmaceutical companies to improve clinical trial efficiency and increase confidence in results SAN FRANCISCO–(BUSINESS WIRE)–#AI–Unlearn\u00ae, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today announced that it has closed […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-780122","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"\nUnlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez\" \/>\n<meta property=\"og:description\" content=\"Led by Insight Partners, financing builds on the company\u2019s momentum in working with leading biopharmaceutical companies to improve clinical trial efficiency and increase confidence in results SAN FRANCISCO--(BUSINESS WIRE)--#AI--Unlearn\u00ae, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today announced that it has closed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-20T06:00:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-11T12:18:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"olomaster\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"olomaster\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\"},\"author\":{\"name\":\"olomaster\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\"},\"headline\":\"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials\",\"datePublished\":\"2022-04-20T06:00:22+00:00\",\"dateModified\":\"2023-07-11T12:18:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\"},\"wordCount\":794,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\",\"name\":\"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-04-20T06:00:22+00:00\",\"dateModified\":\"2023-07-11T12:18:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518\",\"name\":\"olomaster\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g\",\"caption\":\"olomaster\"},\"url\":\"https:\/\/bebeez.it\/en\/author\/olomaster\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez","og_description":"Led by Insight Partners, financing builds on the company\u2019s momentum in working with leading biopharmaceutical companies to improve clinical trial efficiency and increase confidence in results SAN FRANCISCO--(BUSINESS WIRE)--#AI--Unlearn\u00ae, developer of the first machine-learning technology that creates digital twins of patients in clinical trials to enable smaller, faster studies, today announced that it has closed […]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/","og_site_name":"BeBeez","article_published_time":"2022-04-20T06:00:22+00:00","article_modified_time":"2023-07-11T12:18:27+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"author":"olomaster","twitter_card":"summary_large_image","twitter_misc":{"Written by":"olomaster","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/"},"author":{"name":"olomaster","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518"},"headline":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials","datePublished":"2022-04-20T06:00:22+00:00","dateModified":"2023-07-11T12:18:27+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/"},"wordCount":794,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/","name":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-04-20T06:00:22+00:00","dateModified":"2023-07-11T12:18:27+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/unlearn-closes-50-million-series-b-funding-to-advance-the-use-of-its-machine-learning-powered-twinrcts-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Unlearn Closes $50 Million Series B Funding to Advance the Use of Its Machine Learning-Powered TwinRCTs\u2122 in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/f3523ef027b0af56aa28725439cc9518","name":"olomaster","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f27d32333d7dec7da2843c6d51349029304daff2c6c3fb07164f8de234678661?s=96&d=mm&r=g","caption":"olomaster"},"url":"https:\/\/bebeez.it\/en\/author\/olomaster\/"}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/780122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=780122"}],"version-history":[{"count":1,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/780122\/revisions"}],"predecessor-version":[{"id":889237,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/780122\/revisions\/889237"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=780122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=780122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=780122"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=780122"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=780122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}